Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)

Clinical trial NCT06950190 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06950190
Sponsor: Ellis Medicine
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-related Cognitive Impairment

Start date: 2025-06-09
Primary completion: 2027-02-20
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.